Technology Gap Separates OTC Drug Firms From Self-Care Sales Growth
This article was originally published in The Pink Sheet
OTC drug firms should offer more digital tools that guide consumers in product purchases, says a health care marketing executive. The American Pharmacists Association suggests firms also strengthen outreach with pharmacists.
You may also be interested in...
AHPA releases guidance for tea and infusion products on regulatory and liability implications as a result of increasing Prop 65 lawsuits; CHPA files citizen petition urging FDA to act on a CBD pathway; PEW pushes for stronger supplement oversight; and more.
Influencing consumers with facts about health care topics frequently littered with inaccurate advice from non-expert social media sources requires having trust, say consumer health business executives from Bayer, J&J, Sanofi and Taisho Pharmaceutical at the Consumer Healthcare Products Association executive conference. "From a trust perspective, I think that health care is a deeply personal and emotional issue. ... it is definitely important to be fact-based," said Katie Devine, J&J's consumer self-care business global president.
The Acetaminophen Awareness Coalition says its efforts are “validated” by a study finding public awareness campaigns are critical to prevent accidental overdose of OTC drug ingredients. AAC will provide educational materials to 4,600 Walmart stores by the end of 2015, says CHPA.